The Acute Effect of Hydroxychloroquine Sulfate on Hunger, the Plasma Concentration of Orexigenic Peptides and Hedonic Food Intake: A Pilot Study.
Emily Ruilova SosorangaWout VerbeureHannelore GeysenTheo ThijsChristophe MatthysInge DepoortereJan TackPublished in: Nutrients (2023)
The direct infusion of bitter solutions in the gastrointestinal tract can reduce the secretion of orexigenic hormones and influence appetite and food intake. We aimed to explore whether oral ingestion of the bitter tastant hydroxychloroquine sulfate can exert similar effects. Ten lean adult women were included in this double-blind, randomized, two-visit, crossover study. After an overnight fast, each volunteer received film-coated tablets containing 400 mg of hydroxychloroquine sulfate (Plaquenil ® ) or placebo. Plasma-ghrelin, -motilin, -insulin and blood-glucose concentrations were determined every 10 min before and 30 min after feeding; appetite was scored every 10 min. Hunger scores were investigated with a special interest 50-60 min after the ingestion of hydroxychloroquine sulfate, right before a rewarding chocolate milkshake was offered to drink ad libitum. Compared with the placebo, hydroxychloroquine sulfate tended to reduce hunger at the time of interest ( p = 0.10). No effect was found upon subsequent milkshake intake. Motilin plasma concentrations were unaltered, but acyl-ghrelin plasma concentrations decreased after the ingestion of hydroxychloroquine sulfate (t = 40-50; p < 0.05). These data suggest that the oral intake of hydroxychloroquine sulfate tablets reduces subjective hunger via a ghrelin-dependent mechanism but does not affect motilin release, hedonic food intake or insulin levels in healthy women.
Keyphrases
- double blind
- placebo controlled
- blood glucose
- type diabetes
- phase iii
- clinical trial
- weight loss
- polycystic ovary syndrome
- randomized controlled trial
- open label
- low dose
- pregnant women
- intensive care unit
- machine learning
- adipose tissue
- gold nanoparticles
- metabolic syndrome
- phase ii
- pregnancy outcomes
- insulin resistance
- mass spectrometry
- deep learning
- high resolution
- artificial intelligence
- hepatitis b virus
- study protocol
- single molecule
- amino acid
- physical activity
- breast cancer risk
- atomic force microscopy